Skip to main content

Articles

Page 286 of 329

  1. Metastasis represents a major adverse step in the progression of breast carcinoma. Lymph node invasion is the most relevant prognostic factor; however little is known on the molecular events associated with ly...

    Authors: Weiwei Feng, Rosaria Orlandi, Naiqing Zhao, Maria Luisa Carcangiu, Elda Tagliabue, Jia Xu, Robert C Bast Jr and Yinhua Yu
    Citation: BMC Cancer 2010 10:378
  2. According to the different sensitivity of their bone marrow CD34+ cells to in vitro treatment with Etoposide or Mafosfamide, Acute Myeloid Leukaemia (AML) patients in apparent complete remission (CR) after chemot...

    Authors: Marco Ragusa, Giuseppe Avola, Rosario Angelica, Davide Barbagallo, Maria Rosa Guglielmino, Laura R Duro, Alessandra Majorana, Luisa Statello, Loredana Salito, Carla Consoli, Maria Grazia Camuglia, Cinzia Di Pietro, Giuseppe Milone and Michele Purrello
    Citation: BMC Cancer 2010 10:377
  3. Infiltration by macrophages (Mφ) indicates a poor prognosis in breast cancers, in particular by inducing angiogenesis. Our study aimed 1) to investigate the mechanism by which cooperation between Mφ and aggres...

    Authors: Ulrich Joimel, Caroline Gest, Jeannette Soria, Linda-Louise Pritchard, Jérôme Alexandre, Marc Laurent, Emmanuel Blot, Lionel Cazin, Jean-Pierre Vannier, Rémi Varin, Hong Li and Claudine Soria
    Citation: BMC Cancer 2010 10:375
  4. Aimed to assess the relationship between H.Pylori and the clinicopathological features and prognosis of gastric cancer by quantitative detection of H.Pylori.

    Authors: Hai-Bo Qiu, Li-Yi Zhang, Rajiv-Prasad Keshari, Guo-Qiang Wang, Zhi-Wei Zhou, Da-Zhi Xu, Wei Wang, You-Qin Zhan and Wei Li
    Citation: BMC Cancer 2010 10:374
  5. Recent research has yielded a wealth of data underscoring the key role of the cancer microenvironment, especially immune and stromal cells, in the progression of cancer and the development of metastases. Howev...

    Authors: Joanna M Poczobutt, John Tentler, Xian Lu, Pepper J Schedin and Arthur Gutierrez-Hartmann
    Citation: BMC Cancer 2010 10:373
  6. Hypoxia regulates gene expression via the transcription factor HIF (Hypoxia-Inducible Factor). Little is known regarding HIF expression and function in primary bone sarcomas. We describe HIF expression and phe...

    Authors: Helen J Knowles, Karl-Ludwig Schaefer, Uta Dirksen and Nicholas A Athanasou
    Citation: BMC Cancer 2010 10:372
  7. The aims of this study were to determine the accuracy of concurrent core needle biopsy (CNB) and fine needle aspiration biopsy (FNAB) for breast lesions and to estimate the false-negative rate using the two me...

    Authors: Yao-Lung Kuo and Tsai-Wang Chang
    Citation: BMC Cancer 2010 10:371
  8. Chloroquine (CQ), the worldwide used anti-malarial drug, has recently being focused as a potential anti-cancer agent as well as a chemosensitizer when used in combination with anti-cancer drugs. It has been sh...

    Authors: Kazuhito Sasaki, Nelson H Tsuno, Eiji Sunami, Giichiro Tsurita, Kazushige Kawai, Yurai Okaji, Takeshi Nishikawa, Yasutaka Shuno, Kumiko Hongo, Masaya Hiyoshi, Manabu Kaneko, Joji Kitayama, Koki Takahashi and Hirokazu Nagawa
    Citation: BMC Cancer 2010 10:370
  9. Matrix metalloproteinases (MMPs) are enzymes that degrade all the components of extra cellular matrix and collagen. Various types of MMPs are known to be expressed and activated in patients with oral submucous...

    Authors: Ajay K Chaudhary, Mamta Singh, Alok C Bharti, Mangal Singh, Shirish Shukla, Atul K Singh and Ravi Mehrotra
    Citation: BMC Cancer 2010 10:369
  10. The phosphoinositide 3-kinase (PI3K)/Akt pathway is constitutively activated in pancreatic cancer and the mammalian target of rapamycin (mTOR) kinase is an important mediator for its signaling. Our recent in vitr...

    Authors: Milind M Javle, Rachna T Shroff, Henry Xiong, Gauri A Varadhachary, David Fogelman, Shrikanth A Reddy, Darren Davis, Yujian Zhang, Robert A Wolff and James L Abbruzzese
    Citation: BMC Cancer 2010 10:368
  11. MicroRNAs (miRNAs) can function as either oncogenes or tumor suppressor genes via regulation of cell proliferation and/or apoptosis. MiR-221 and miR-222 were discovered to induce cell growth and cell cycle pro...

    Authors: Zhang Chun-zhi, Han Lei, Zhang An-ling, Fu Yan-chao, Yue Xiao, Wang Guang-xiu, Jia Zhi-fan, Pu Pei-yu, Zhang Qing-yu and Kang Chun-sheng
    Citation: BMC Cancer 2010 10:367
  12. DNA methylation and histone acetylation are epigenetic modifications that act as regulators of gene expression. Aberrant epigenetic gene silencing in tumours is a frequent event, yet the factors which dictate ...

    Authors: David Mossman, Kyu-Tae Kim and Rodney J Scott
    Citation: BMC Cancer 2010 10:366
  13. Lymph node metastasis is a critical event in the progression of tongue squamous cell carcinoma (TSCC). The identification of biomarkers associated with the metastatic process would provide critical prognostic ...

    Authors: Xiqiang Liu, Anxun Wang, Lorenzo Lo Muzio, Antonia Kolokythas, Shihu Sheng, Corrado Rubini, Hui Ye, Fei Shi, Tianwei Yu, David L Crowe and Xiaofeng Zhou
    Citation: BMC Cancer 2010 10:365
  14. The formation of metastasis is the most common cause of death in patients with lung cancer. A major implement to understand the molecular mechanisms involved in lung cancer metastasis has been the lack of suit...

    Authors: Deshui Jia, Mingxia Yan, Xiaomin Wang, Xiangfang Hao, Linhui Liang, Lei Liu, Hanwei Kong, Xianghuo He, Jinjun Li and Ming Yao
    Citation: BMC Cancer 2010 10:364
  15. The majority of cancer patients experience dramatic weight loss, due to cachexia and consisting of skeletal muscle and fat tissue wasting. Cachexia is a negative prognostic factor, interferes with therapy and ...

    Authors: Paola Aulino, Emanuele Berardi, Veronica M Cardillo, Emanuele Rizzuto, Barbara Perniconi, Carla Ramina, Fabrizio Padula, Enrico P Spugnini, Alfonso Baldi, Fabio Faiola, Sergio Adamo and Dario Coletti
    Citation: BMC Cancer 2010 10:363
  16. Molecular heterogeneity of colorectal carcinoma (CRC) is well recognized, forming the rationale for molecular tests required before administration of some of the novel targeted therapies that now are rapidly e...

    Authors: Michael Linnebacher, Claudia Maletzki, Christiane Ostwald, Ulrike Klier, Mathias Krohn, Ernst Klar and Friedrich Prall
    Citation: BMC Cancer 2010 10:362
  17. Psychological distress (i.e. depression and anxiety) is a strong predictor of functional status and other aspects of quality of life in autologous stem cell transplantation following high-dose chemotherapy. Tr...

    Authors: Annemarie MJ Braamse, Berno van Meijel, Otto Visser, Patricia van Oppen, Annette D Boenink, Corien Eeltink, Pim Cuijpers, Peter C Huijgens, Aartjan TF Beekman and Joost Dekker
    Citation: BMC Cancer 2010 10:361
  18. A patient with nevoid basal cell carcinoma syndrome (Gorlin syndrome) presented with two unusual clinical features, i.e. adenocarcinoma of the small bowel and extensive mesenchymal proliferation of the lower g...

    Authors: Peter M Prodinger, Mario Sarbia, Jörg Maßmann, Christian Straka, Günther Meyer and Ortrud K Steinlein
    Citation: BMC Cancer 2010 10:360
  19. Synuclein gamma (SNCG), initially identified as a breast cancer specific gene, is aberrantly expressed in many different malignant tumors but rarely expressed in matched nonneoplastic adjacent tissues. In this...

    Authors: Caiyun Liu, Bin Dong, Aiping Lu, Like Qu, Xiaofang Xing, Lin Meng, Jian Wu, Y Eric Shi and Chengchao Shou
    Citation: BMC Cancer 2010 10:359
  20. Optimal management and outcome of primary gastric lymphoma (PGL) have not been well defined in the rituximab era. This study aimed to analyze the clinical characteristics, prognostic factors, and roles of diff...

    Authors: JiaJia Huang, WenQi Jiang, RuiHua Xu, HuiQiang Huang, Yue Lv, ZhongJun Xia, XiaoFei Sun, ZhongZhen Guan, TongYu Lin and ZhiMing Li
    Citation: BMC Cancer 2010 10:358
  21. There is a paucity of recent epidemiological data on bone cancers. The aim of this study was to describe incidence and survival patterns for bone cancers diagnosed during 1981 - 2002.

    Authors: Rachel Eyre, Richard G Feltbower, Peter W James, Karen Blakey, Emmanuel Mubwandarikwa, David Forman, Patricia A McKinney, Mark S Pearce and Richard JQ McNally
    Citation: BMC Cancer 2010 10:357
  22. Hepatocellular carcinoma (HCC) is one of the world's leading causes of death among cancer patients. It is important to find a new biomarker that diagnoses HCC and monitors its treatment. In our previous work, ...

    Authors: Huaqing Cui, Feng Wu, Yanling Sun, Guocai Fan and Qingming Wang
    Citation: BMC Cancer 2010 10:356
  23. Targeted colonosocopic screening is recommended for first-degree relatives of colorectal cancer patients diagnosed before the age of 60 and offers the possibility of reducing morbidity and mortality, but parti...

    Authors: Myriam Taouqi, Isabelle Ingrand, Michel Beauchant, Virginie Migeot and Pierre Ingrand
    Citation: BMC Cancer 2010 10:355
  24. In recent years, some miRNAs have been reported to be connected closely with the development of human hepatocellular carcinoma. In our previous studies, a set of miRNAs were revealed to be dysregulated in HCC ...

    Authors: Jipeng Li, Hanjiang Fu, Chengwang Xu, Yi Tie, Ruiyun Xing, Jie Zhu, Yide Qin, Zhixian Sun and Xiaofei Zheng
    Citation: BMC Cancer 2010 10:354
  25. Hsp90 (heat shock protein90) is a chaperone protein essential for preserving and regulating the function of various cellular proteins. Elevated Hsp90 expression seems to be a trait of breast cancer and may be ...

    Authors: Flora Zagouri, Theodoros N Sergentanis, Afrodite Nonni, Christos A Papadimitriou, Nikolaos V Michalopoulos, Philip Domeyer, George Theodoropoulos, Andreas Lazaris, Effstratios Patsouris, Eleni Zogafos, Anastazia Pazaiti and George C Zografos
    Citation: BMC Cancer 2010 10:353
  26. Glutathione S-transferase pi (GST pi) is a subgroup of GST family, which provides cellular protection against free radical and carcinogenic compounds due to its detoxifying function. Expression patterns of GST...

    Authors: Zhihui Wang, Wei He, Guanrui Yang, Junsheng Wang, Zhong Wang, Jahn M Nesland, Ruth Holm and Zhenhe Suo
    Citation: BMC Cancer 2010 10:352
  27. Novel therapeutic agents that selectively induce tumor cell death are urgently needed in the clinical management of cancers. Such agents would constitute effective adjuvant approaches to traditional chemothera...

    Authors: W Wei-Lynn Wong, Paul C Boutros, Amanda R Wasylishen, Kristal D Guckert, Erin M O'Brien, Rebecca Griffiths, Anna R Martirosyan, Christina Bros, Igor Jurisica, Richard F Langler and Linda Z Penn
    Citation: BMC Cancer 2010 10:351
  28. Risk estimation of gastrointestinal stromal tumours (GIST) is based on tumour size and mitotic rate according to the National Institutes of Health consensus classification. The indication for adjuvant treatmen...

    Authors: Julian Dorn, Hanno Spatz, Michael Schmieder, Thomas FE Barth, Annette Blatz, Doris Henne-Bruns, Uwe Knippschild and Klaus Kramer
    Citation: BMC Cancer 2010 10:350
  29. Development of innovative, effective therapies against recurrent/chemotherapy-resistant ovarian cancer remains a high priority. Using high-throughput technologies to analyze genetic fingerprints of ovarian can...

    Authors: Emiliano Cocco, Francesca Casagrande, Stefania Bellone, Christine E Richter, Marta Bellone, Paola Todeschini, Jennie C Holmberg, Han Hsuan Fu, Michele K Montagna, Gil Mor, Peter E Schwartz, Dan Arin-Silasi, Masoud Azoudi, Thomas J Rutherford, Maysa Abu-Khalaf, Sergio Pecorelli…
    Citation: BMC Cancer 2010 10:349
  30. Deregulated c-Myc expression is a hallmark of several human cancers where it promotes proliferation and an aggressive tumour phenotype. Myc overexpression is associated with reduced activity of Rel/NF-κB, tran...

    Authors: Ulrich Keller, Jürgen Huber, Jonas A Nilsson, Mohammad Fallahi, Mark A Hall, Christian Peschel and John L Cleveland
    Citation: BMC Cancer 2010 10:348
  31. Recently, serum 25-hydroxyvitamin D (25OHD) levels were shown to be associated with the survival of patients with colorectal cancer. However, 25OHD levels were measured a median of 6 years before diagnosis or ...

    Authors: Hidetoshi Mezawa, Tsutomu Sugiura, Michiaki Watanabe, Chihiro Norizoe, Daisuke Takahashi, Akira Shimojima, Seryna Tamez, Yusuke Tsutsumi, Katsuhiko Yanaga and Mitsuyoshi Urashima
    Citation: BMC Cancer 2010 10:347
  32. Aneuploidy has long been recognized to be associated with cancer. A growing body of evidence suggests that tumorigenesis, the formation of new tumors, can be attributed to some extent to errors occurring at th...

    Authors: Yao Li, Arthur Berg, Louie R Wu, Zhong Wang, Gang Chen and Rongling Wu
    Citation: BMC Cancer 2010 10:346
  33. Compared to healthy controls, cancer patients have a higher risk of unemployment, which has negative social and economic impacts on the patients and on society at large. Therefore, return-to-work of cancer pat...

    Authors: Sietske J Tamminga, Angela GEM de Boer, Jos HAM Verbeek, Taina Taskila and Monique HW Frings-Dresen
    Citation: BMC Cancer 2010 10:345
  34. In Tanzania, the International Working Formulation [WF] rather than the WHO Classification is still being used in diagnosing malignant lymphomas (ML) and the biological characterization including the HIV/EBV a...

    Authors: Amos R Mwakigonja, Ephata E Kaaya, Thomas Heiden, German Wannhoff, Juan Castro, Fatemeh Pak, Anna Porwit and Peter Biberfeld
    Citation: BMC Cancer 2010 10:344
  35. Modulation of pre-mRNA splicing by antisense molecules is a promising mechanism of action for gene therapeutic drugs. In this study, we have examined the potential of peptide nucleic acid (PNA) 9-aminoacridine...

    Authors: Takehiko Shiraishi, Jonhard Eysturskarð and Peter E Nielsen
    Citation: BMC Cancer 2010 10:342
  36. The oncofetal protein insulin-like growth factor II mRNA binding protein 3 (IMP3) is an important factor for cell-migration and adhesion in malignancies. Recent studies have shown a remarkable overexpression o...

    Authors: Kristian Ikenberg, Florian R Fritzsche, Ursina Zuerrer-Haerdi, Irina Hofmann, Thomas Hermanns, Helge Seifert, Michael Müntener, Maurizio Provenzano, Tullio Sulser, Silvia Behnke, Josefine Gerhardt, Ashkan Mortezavi, Peter Wild, Ferdinand Hofstädter, Maximilian Burger, Holger Moch…
    Citation: BMC Cancer 2010 10:341
  37. Activity of cetuximab, a chimeric monoclonal antibody targeting the epidermal growth factor receptor, is largely attributed to its direct antiproliferative and proapoptotic effects. Antibody-dependent cell-med...

    Authors: Raphaël Maréchal, Jef De Schutter, Nathalie Nagy, Pieter Demetter, Arnaud Lemmers, Jacques Devière, Isabelle Salmon, Sabine Tejpar and Jean-Luc Van Laethem
    Citation: BMC Cancer 2010 10:340
  38. Ovarian germ cell tumours (OGCT) are rare but are usually curable with chemotherapy, even when presenting with advanced disease. The majority of OGCT produce the tumour markers, hCG and/or AFP which can be hel...

    Authors: Serena Rakha, Clare Bayliss, Frances Sanderson, Richard Smith, Michael Seckl and Philip Savage
    Citation: BMC Cancer 2010 10:338
  39. We conducted a systematic review and meta-analysis to clarify the risk of early and late cardiotoxicity of anthracycline agents in patients treated for breast or ovarian cancer, lymphoma, myeloma or sarcoma.

    Authors: Lesley A Smith, Victoria R Cornelius, Christopher J Plummer, Gill Levitt, Mark Verrill, Peter Canney and Alison Jones
    Citation: BMC Cancer 2010 10:337
  40. Gene expression profiling may improve prognostic accuracy in patients with early breast cancer. Our objective was to demonstrate that it is possible to develop a simple molecular signature to predict distant r...

    Authors: Iker Sánchez-Navarro, Angelo Gámez-Pozo, Álvaro Pinto, David Hardisson, Rosario Madero, Rocío López, Belén San José, Pilar Zamora, Andrés Redondo, Jaime Feliu, Paloma Cejas, Manuel González Barón, Juan Ángel Fresno Vara and Enrique Espinosa
    Citation: BMC Cancer 2010 10:336
  41. MED28 (also known as EG-1 and magicin) has been implicated in transcriptional control, signal regulation, and cell proliferation. MED28 has also been associated with tumor progression in in vitro and in vivo mode...

    Authors: Nam K Yoon, Erin L Maresh, Yahya Elshimali, Ai Li, Steve Horvath, David B Seligson, David Chia and Lee Goodglick
    Citation: BMC Cancer 2010 10:335
  42. Serum CD26 (sCD26) levels were previously found diminished in colorectal cancer (CRC) patients compared to healthy donors, suggesting its potential utility for early diagnosis. Therefore we aimed to estimate t...

    Authors: Loretta De Chiara, Ana M Rodríguez-Piñeiro, Francisco J Rodríguez-Berrocal, Oscar J Cordero, David Martínez-Ares and María Páez de la Cadena
    Citation: BMC Cancer 2010 10:333
  43. Diagnosing colorectal cancer (CRC) at an early stage improves survival. To what extent any delay affects outcome once patients are symptomatic is still unclear.

    Authors: Jochim S Terhaar sive Droste, Frank A Oort, René WM van der Hulst, Veerle MH Coupé, Mike E Craanen, Gerrit A Meijer, Linde M Morsink, Otto Visser, Roy LJ van Wanrooij and Chris JJ Mulder
    Citation: BMC Cancer 2010 10:332
  44. Proteolytic cleavage of the extracellular domain (EpEx) of Epithelial cell adhesion molecule (EpCAM) and nuclear signaling by its intracellular oncogenic domain Ep-ICD has recently been implicated in increased...

    Authors: Ranju Ralhan, Jun Cao, Terence Lim, Christina MacMillan, Jeremy L Freeman and Paul G Walfish
    Citation: BMC Cancer 2010 10:331
  45. The alternatively spliced V region or type III connecting segment III (IIICS) of fibronectin is important in early development, wound healing, and tumorigenesis, however, its role in oral cancer has not been f...

    Authors: Pachiyappan Kamarajan, Angeles Garcia-Pardo, Nisha J D'Silva and Yvonne L Kapila
    Citation: BMC Cancer 2010 10:330
  46. The HMGA2 gene, coding for an architectural transcription factor involved in mesenchymal embryogenesis, is frequently deranged by translocation and/or amplification in mesenchymal tumours, generally leading to...

    Authors: Jørn Henriksen, Marianne Stabell, Leonardo A Meza-Zepeda, Silje AU Lauvrak, Moustapha Kassem and Ola Myklebost
    Citation: BMC Cancer 2010 10:329

Featured videos

View featured videos from across the BMC-series journals